Skip to main content
Erschienen in: Cancer Causes & Control 7/2010

01.07.2010 | Original paper

A prospective study of one-carbon metabolism biomarkers and risk of renal cell carcinoma

verfasst von: Todd M. Gibson, Stephanie J. Weinstein, Susan T. Mayne, Ruth M. Pfeiffer, Jacob Selhub, Philip R. Taylor, Jarmo Virtamo, Demetrius Albanes, Rachael Stolzenberg-Solomon

Erschienen in: Cancer Causes & Control | Ausgabe 7/2010

Einloggen, um Zugang zu erhalten

Abstract

Objective

Previous studies have found associations between one-carbon metabolism factors and risk of several cancers, but little is known regarding renal cell carcinoma (RCC). We conducted a nested case–control study within the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study, a prospective study of Finnish male smokers aged 50–69 at baseline.

Methods

Prediagnostic folate, vitamin B6, vitamin B12, cysteine, riboflavin, and homocysteine concentrations were measured in fasting serum from 224 incident RCC cases and 224 controls (matched on age and date of serum collection). Conditional logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs), adjusted for potential confounders.

Results

Serum folate tended to be inversely associated with RCC, compared to the first quartile, the odds ratios (95% CI) for subsequent quartiles were 0.62 (0.35–1.08), 0.52 (0.29–0.93), and 0.67 (0.37–1.20) (P-trend = 0.19). When modeled as a threshold effect, subjects in the lowest serum folate quartile (≤6.64 nmol/l), which corresponds to deficient folate status, had a significant increased RCC risk (OR = 1.68, 95% CI 1.06–2.65) compared to those with higher serum folate. The other one-carbon metabolism biomarkers were not associated with RCC.

Conclusions

This study in male smokers suggests that deficient folate status may increase risk of RCC, but confirmation is needed in other epidemiologic studies that include women and non-smokers.
Literatur
1.
Zurück zum Zitat Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr (1999) Rising incidence of renal cell cancer in the United States. JAMA 281:1628–1631CrossRefPubMed Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr (1999) Rising incidence of renal cell cancer in the United States. JAMA 281:1628–1631CrossRefPubMed
2.
Zurück zum Zitat Ries LAG, Melbert D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Eisner MP, Horner MJ, Howlader N, Hayat M, Hankey BF, Edwards BK (eds) (http://seer.cancer.gov/csr/1975_2004/ based on November 2006 SEER data submission, posted to the SEER web site 2007) SEER Cancer Statistics Review, 1975-2004. Bethesda, MD: National Cancer Institute Ries LAG, Melbert D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Eisner MP, Horner MJ, Howlader N, Hayat M, Hankey BF, Edwards BK (eds) (http://​seer.​cancer.​gov/​csr/​1975_​2004/​ based on November 2006 SEER data submission, posted to the SEER web site 2007) SEER Cancer Statistics Review, 1975-2004. Bethesda, MD: National Cancer Institute
3.
Zurück zum Zitat Lipworth L, Tarone RE, McLaughlin JK (2006) The epidemiology of renal cell carcinoma. J Urol 176:2353–2358CrossRefPubMed Lipworth L, Tarone RE, McLaughlin JK (2006) The epidemiology of renal cell carcinoma. J Urol 176:2353–2358CrossRefPubMed
4.
Zurück zum Zitat McLaughlin JK, Lindblad P, Mellemgaard A et al (1995) International renal-cell cancer study I. Tobacco use. Int J Cancer 60:194–198 McLaughlin JK, Lindblad P, Mellemgaard A et al (1995) International renal-cell cancer study I. Tobacco use. Int J Cancer 60:194–198
5.
Zurück zum Zitat McLaughlin JK, Lipworth L (2000) Epidemiologic aspects of renal cell cancer. Semin Oncol 27:115–123PubMed McLaughlin JK, Lipworth L (2000) Epidemiologic aspects of renal cell cancer. Semin Oncol 27:115–123PubMed
6.
Zurück zum Zitat Moore LE, Wilson RT, Campleman SL (2005) Lifestyle factors, exposures, genetic susceptibility, and renal cell cancer risk: a review. Cancer Invest 23:240–255CrossRefPubMed Moore LE, Wilson RT, Campleman SL (2005) Lifestyle factors, exposures, genetic susceptibility, and renal cell cancer risk: a review. Cancer Invest 23:240–255CrossRefPubMed
7.
Zurück zum Zitat Lee JE, Giovannucci E, Smith-Warner SA, Spiegelman D, Willett WC, Curhan GC (2006) Intakes of fruits, vegetables, vitamins A, C, and E, and carotenoids and risk of renal cell cancer. Cancer Epidemiol Biomarkers Prev 15:2445–2452CrossRefPubMed Lee JE, Giovannucci E, Smith-Warner SA, Spiegelman D, Willett WC, Curhan GC (2006) Intakes of fruits, vegetables, vitamins A, C, and E, and carotenoids and risk of renal cell cancer. Cancer Epidemiol Biomarkers Prev 15:2445–2452CrossRefPubMed
8.
Zurück zum Zitat Rashidkhani B, Lindblad P, Wolk A (2005) Fruits, vegetables and risk of renal cell carcinoma: a prospective study of Swedish women. Int J Cancer 113:451–455CrossRefPubMed Rashidkhani B, Lindblad P, Wolk A (2005) Fruits, vegetables and risk of renal cell carcinoma: a prospective study of Swedish women. Int J Cancer 113:451–455CrossRefPubMed
9.
Zurück zum Zitat van Dijk BA, Schouten LJ, Kiemeney LA, Goldbohm RA, van den Brandt PA (2005) Vegetable and fruit consumption and risk of renal cell carcinoma: results from the Netherlands Cohort Study. Int J Cancer 117:648–654CrossRefPubMed van Dijk BA, Schouten LJ, Kiemeney LA, Goldbohm RA, van den Brandt PA (2005) Vegetable and fruit consumption and risk of renal cell carcinoma: results from the Netherlands Cohort Study. Int J Cancer 117:648–654CrossRefPubMed
10.
Zurück zum Zitat Weikert S, Boeing H, Pischon T, Olsen A, Tjonneland A et al (2006) Fruits and vegetables and renal cell carcinoma: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 118:3133–3139CrossRefPubMed Weikert S, Boeing H, Pischon T, Olsen A, Tjonneland A et al (2006) Fruits and vegetables and renal cell carcinoma: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 118:3133–3139CrossRefPubMed
11.
Zurück zum Zitat Bertoia M, Albanes D, Mayne ST, Mannisto S, Virtamo J, Wright ME (2009) No association between fruit, vegetables, antioxidant nutrients and risk of renal cell carcinoma. Int J Cancer Bertoia M, Albanes D, Mayne ST, Mannisto S, Virtamo J, Wright ME (2009) No association between fruit, vegetables, antioxidant nutrients and risk of renal cell carcinoma. Int J Cancer
12.
Zurück zum Zitat Lee JE, Mannisto S, Spiegelman D et al (2009) Intakes of fruit, vegetables, and carotenoids and renal cell cancer risk: a pooled analysis of 13 prospective studies. Cancer Epidemiol Biomarkers Prev 18:1730–1739CrossRefPubMed Lee JE, Mannisto S, Spiegelman D et al (2009) Intakes of fruit, vegetables, and carotenoids and renal cell cancer risk: a pooled analysis of 13 prospective studies. Cancer Epidemiol Biomarkers Prev 18:1730–1739CrossRefPubMed
13.
Zurück zum Zitat Stover PJ (2004) Physiology of folate and vitamin B12 in health and disease. Nutr Rev 62:12 (discussion S13)CrossRef Stover PJ (2004) Physiology of folate and vitamin B12 in health and disease. Nutr Rev 62:12 (discussion S13)CrossRef
14.
Zurück zum Zitat Friso S, Choi SW (2005) Gene-nutrient interactions in one-carbon metabolism. Curr Drug Metab 6:37–46CrossRefPubMed Friso S, Choi SW (2005) Gene-nutrient interactions in one-carbon metabolism. Curr Drug Metab 6:37–46CrossRefPubMed
15.
Zurück zum Zitat Bailey LB, Gregory JF III (1999) Folate metabolism and requirements. J Nutr 129:779–782PubMed Bailey LB, Gregory JF III (1999) Folate metabolism and requirements. J Nutr 129:779–782PubMed
16.
Zurück zum Zitat Clarke S, Banfield K (2001) S-adenosylmethionine-dependent methyltransferases. In: Carmel R, Jacobson DW (eds) Homocysteine in health and disease. Cambridge Press, Cambridge Clarke S, Banfield K (2001) S-adenosylmethionine-dependent methyltransferases. In: Carmel R, Jacobson DW (eds) Homocysteine in health and disease. Cambridge Press, Cambridge
17.
Zurück zum Zitat Franco R, Schoneveld OJ, Pappa A, Panayiotidis MI (2007) The central role of glutathione in the pathophysiology of human diseases. Arch Physiol Biochem 113:234–258CrossRefPubMed Franco R, Schoneveld OJ, Pappa A, Panayiotidis MI (2007) The central role of glutathione in the pathophysiology of human diseases. Arch Physiol Biochem 113:234–258CrossRefPubMed
18.
Zurück zum Zitat Choi SW, Mason JB (2000) Folate and carcinogenesis: an integrated scheme. J Nutr 130:129–132PubMed Choi SW, Mason JB (2000) Folate and carcinogenesis: an integrated scheme. J Nutr 130:129–132PubMed
19.
Zurück zum Zitat Kim Y-I (1999) Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem 10:66–88CrossRefPubMed Kim Y-I (1999) Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem 10:66–88CrossRefPubMed
20.
Zurück zum Zitat Kim Y-I (2007) Folate and colorectal cancer: an evidence-based critical review. Mol Nutr Food Res 51:267–292CrossRefPubMed Kim Y-I (2007) Folate and colorectal cancer: an evidence-based critical review. Mol Nutr Food Res 51:267–292CrossRefPubMed
21.
Zurück zum Zitat Larsson SC, Giovannucci E, Wolk A (2006) Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis. Gastroenterology 131:1271–1283CrossRefPubMed Larsson SC, Giovannucci E, Wolk A (2006) Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis. Gastroenterology 131:1271–1283CrossRefPubMed
22.
Zurück zum Zitat World Cancer Research/Fund/American Institute for Cancer Research (2007) Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective. AICR, Washington, DC World Cancer Research/Fund/American Institute for Cancer Research (2007) Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective. AICR, Washington, DC
23.
Zurück zum Zitat Stolzenberg-Solomon RZ, Albanes D, Nieto FJ et al (1999) Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers. J Natl Cancer Inst 91:535–541CrossRefPubMed Stolzenberg-Solomon RZ, Albanes D, Nieto FJ et al (1999) Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers. J Natl Cancer Inst 91:535–541CrossRefPubMed
24.
Zurück zum Zitat Moore LE, Hung R, Karami S, Boffetta P, Berndt S, Hsu CC (2008) Folate metabolism genes, vegetable intake and renal cancer risk in central Europe. Int J Cancer 122:1710–1715CrossRefPubMed Moore LE, Hung R, Karami S, Boffetta P, Berndt S, Hsu CC (2008) Folate metabolism genes, vegetable intake and renal cancer risk in central Europe. Int J Cancer 122:1710–1715CrossRefPubMed
25.
Zurück zum Zitat The Alpha-Tocopherol Beta-Carotene Cancer Prevention Study Group (1994) The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. Ann Epidemiol 4:1–10CrossRef The Alpha-Tocopherol Beta-Carotene Cancer Prevention Study Group (1994) The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. Ann Epidemiol 4:1–10CrossRef
26.
Zurück zum Zitat Korhonen P, Malila N, Pukkala E, Teppo L, Albanes D, Virtamo J (2002) The Finnish cancer registry as follow-up source of a large trial cohort—accuracy and delay. Acta Oncol 41:381–388CrossRefPubMed Korhonen P, Malila N, Pukkala E, Teppo L, Albanes D, Virtamo J (2002) The Finnish cancer registry as follow-up source of a large trial cohort—accuracy and delay. Acta Oncol 41:381–388CrossRefPubMed
27.
Zurück zum Zitat Shin-Buehring Y, Rasshofer R, Endres WA (1981) A new enzymatic method for pyridoxal-5′ phosphate determination. J Inherit Metab Disorders 4:123–124CrossRef Shin-Buehring Y, Rasshofer R, Endres WA (1981) A new enzymatic method for pyridoxal-5′ phosphate determination. J Inherit Metab Disorders 4:123–124CrossRef
28.
Zurück zum Zitat Araki A, Sako Y (1987) Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 422:43–52CrossRefPubMed Araki A, Sako Y (1987) Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 422:43–52CrossRefPubMed
29.
Zurück zum Zitat Zempleni J, Link G, Kübler W (1992) The transport of thiamine, riboflavin and pyridoxal 5′-phosphate by human placenta. Int J Vitam Nutr Res 62:165–172PubMed Zempleni J, Link G, Kübler W (1992) The transport of thiamine, riboflavin and pyridoxal 5′-phosphate by human placenta. Int J Vitam Nutr Res 62:165–172PubMed
30.
Zurück zum Zitat Fears TR, Ziegler RG, Donaldson JL et al (2002) Reproducibility studies and interlaboratory concordance for androgen assays of male plasma hormone levels. Cancer Epidemiol Biomarkers Prev 11:785–789PubMed Fears TR, Ziegler RG, Donaldson JL et al (2002) Reproducibility studies and interlaboratory concordance for androgen assays of male plasma hormone levels. Cancer Epidemiol Biomarkers Prev 11:785–789PubMed
31.
Zurück zum Zitat Pietinen P, Hartman AM, Haapa E et al (1988) Reproducibility and validity of dietary assessment instruments: I. A self-administered food use questionnaire with a portion size picture booklet. Am. J. Epidemiol. 128:655–666 Pietinen P, Hartman AM, Haapa E et al (1988) Reproducibility and validity of dietary assessment instruments: I. A self-administered food use questionnaire with a portion size picture booklet. Am. J. Epidemiol. 128:655–666
32.
Zurück zum Zitat Willett W, Stampfer MJ (1986) Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 124:17–27PubMed Willett W, Stampfer MJ (1986) Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 124:17–27PubMed
33.
Zurück zum Zitat Mason JB (2003) Biomarkers of nutrient exposure and status in one-carbon (methyl) metabolism. J Nutr 133:941S–947SPubMed Mason JB (2003) Biomarkers of nutrient exposure and status in one-carbon (methyl) metabolism. J Nutr 133:941S–947SPubMed
34.
Zurück zum Zitat Kim Y-I (2008) Folic acid supplementation and cancer risk: point. Cancer Epidemiol Biomarkers Prev 17:2220–2225CrossRefPubMed Kim Y-I (2008) Folic acid supplementation and cancer risk: point. Cancer Epidemiol Biomarkers Prev 17:2220–2225CrossRefPubMed
35.
Zurück zum Zitat Ulrich CM (2008) Folate and cancer prevention—where to next? Counterpoint. Cancer Epidemiol Biomarkers Prev 17:2226–2230CrossRefPubMed Ulrich CM (2008) Folate and cancer prevention—where to next? Counterpoint. Cancer Epidemiol Biomarkers Prev 17:2226–2230CrossRefPubMed
36.
Zurück zum Zitat Alfthan G, Laurinen MS, Valsta LM, Pastinen T, Aro A (2003) Folate intake, plasma folate and homocysteine status in a random Finnish population. Eur J Clin Nutr 57:81–88CrossRefPubMed Alfthan G, Laurinen MS, Valsta LM, Pastinen T, Aro A (2003) Folate intake, plasma folate and homocysteine status in a random Finnish population. Eur J Clin Nutr 57:81–88CrossRefPubMed
37.
Zurück zum Zitat Brevik A, Vollset SE, Tell GS et al (2005) Plasma concentration of folate as a biomarker for the intake of fruit and vegetables: The Hordaland Homocysteine Study. Am J Clin Nutr 81:434–439PubMed Brevik A, Vollset SE, Tell GS et al (2005) Plasma concentration of folate as a biomarker for the intake of fruit and vegetables: The Hordaland Homocysteine Study. Am J Clin Nutr 81:434–439PubMed
38.
Zurück zum Zitat Dietrich M, Brown CJ, Block G (2005) The effect of folate fortification of cereal-grain products on blood folate status, dietary folate intake, and dietary folate sources among adult non-supplement users in the United States. J Am Coll Nutr 24:266–274PubMed Dietrich M, Brown CJ, Block G (2005) The effect of folate fortification of cereal-grain products on blood folate status, dietary folate intake, and dietary folate sources among adult non-supplement users in the United States. J Am Coll Nutr 24:266–274PubMed
39.
Zurück zum Zitat Frosst P, Blom HJ, Milos R et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111–113CrossRefPubMed Frosst P, Blom HJ, Milos R et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111–113CrossRefPubMed
40.
Zurück zum Zitat Herbert V (1998) Folic acid. In: Shils M, Olson J, Shike M, Ross AC (eds) Modern nutrition in health and disease, 9th edn. Williams, Wilkins, Baltimore, pp 443–446 Herbert V (1998) Folic acid. In: Shils M, Olson J, Shike M, Ross AC (eds) Modern nutrition in health and disease, 9th edn. Williams, Wilkins, Baltimore, pp 443–446
41.
Zurück zum Zitat Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH (1993) Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270:2693–2698CrossRefPubMed Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH (1993) Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270:2693–2698CrossRefPubMed
42.
Zurück zum Zitat Mannino DM, Mulinare J, Ford ES, Schwartz J (2003) Tobacco smoke exposure and decreased serum and red blood cell folate levels: data from the Third National Health and Nutrition Examination Survey. Nicotine Tob Res 5:357–362CrossRefPubMed Mannino DM, Mulinare J, Ford ES, Schwartz J (2003) Tobacco smoke exposure and decreased serum and red blood cell folate levels: data from the Third National Health and Nutrition Examination Survey. Nicotine Tob Res 5:357–362CrossRefPubMed
43.
Zurück zum Zitat Gabriel HE, Crott JW, Ghandour H et al (2006) Chronic cigarette smoking is associated with diminished folate status, altered folate form distribution, and increased genetic damage in the buccal mucosa of healthy adults. Am J Clin Nutr 83:835–841PubMed Gabriel HE, Crott JW, Ghandour H et al (2006) Chronic cigarette smoking is associated with diminished folate status, altered folate form distribution, and increased genetic damage in the buccal mucosa of healthy adults. Am J Clin Nutr 83:835–841PubMed
44.
Zurück zum Zitat Piyathilake CJ, Macaluso M, Hine RJ, Richards EW, Krumdieck CL (1994) Local and systemic effects of cigarette smoking on folate and vitamin B-12. Am J Clin Nutr 60:559–566PubMed Piyathilake CJ, Macaluso M, Hine RJ, Richards EW, Krumdieck CL (1994) Local and systemic effects of cigarette smoking on folate and vitamin B-12. Am J Clin Nutr 60:559–566PubMed
45.
Zurück zum Zitat Pfeiffer CM, Johnson CL, Jain RB et al (2007) Trends in blood folate and vitamin B-12 concentrations in the United States, 1988 2004. Am J Clin Nutr 86:718–727PubMed Pfeiffer CM, Johnson CL, Jain RB et al (2007) Trends in blood folate and vitamin B-12 concentrations in the United States, 1988 2004. Am J Clin Nutr 86:718–727PubMed
Metadaten
Titel
A prospective study of one-carbon metabolism biomarkers and risk of renal cell carcinoma
verfasst von
Todd M. Gibson
Stephanie J. Weinstein
Susan T. Mayne
Ruth M. Pfeiffer
Jacob Selhub
Philip R. Taylor
Jarmo Virtamo
Demetrius Albanes
Rachael Stolzenberg-Solomon
Publikationsdatum
01.07.2010
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 7/2010
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-010-9534-5

Weitere Artikel der Ausgabe 7/2010

Cancer Causes & Control 7/2010 Zur Ausgabe

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

06.05.2024 Kolonkarzinom Nachrichten

Menschen mit linksseitigem Kolonkarzinom leben im Mittel zweieinhalb Jahre länger als solche mit rechtsseitigem Tumor. Auch aktuell ist das Sterberisiko bei linksseitigen Tumoren US-Daten zufolge etwa um 11% geringer als bei rechtsseitigen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.